Our Blog

Cellebration Life Sciences Inc. is changing how we treat terminal illnesses with groundbreaking scientific research for Type 2 Diabetes

Researchers discovered stem cells in 1981, and scientists have been researching stem cell therapy. In the last four decades, stem cell therapy has become a promising scientific research topic. In this endeavor, Cellebration Life Sciences Inc is pioneering the successful treatment of diseases like Type 2 Diabetes. Under Tim Kopatich’s leadership, the CEO and co-founder of Cellebration Life Sciences Inc, Dr. Anand Srivastava, the Chief Science Officer have collaborated to take this research to the next level.

The World Health Organization estimates that nearly 500 million people worldwide have or are predetermined to have diabetes, representing a treatment market worth more than $800 billion annually. The success of Cellebration’s Clinical Trial is expected to significantly alter the global strategy for treating this devastating disease, with significant benefits accruing to Cellebration’s shareholders.

Let’s learn more about stem cells and the contribution of Cellebration and their curative treatment.

What are Stem Cells & Where Do They Come from?

Stem cells, as the master cells of the human body, allow us to grow, age, and heal. They are in charge of the entire human body’s development and can renew themselves indefinitely through cell division. They can also develop into cells with specific functions, such as red blood cells or muscle cells.

Stem cells are the most natural way for our bodies to treat and heal themselves, acting as an internal repair system.

Stem cells are derived from bone marrow, fatty tissue or adipose, dental pulp, umbilical cord, and umbilical blood.

Can Stem Cells Be the Paradigm Shift in Medicine?

Imagine a future when we no longer rely on medicines, surgeries, or drugs to resolve our health problems. Stem cells can help our bodies to heal themselves and find curative treatment for almost every disease.

In less than 5 years, the medical world will experience a significant transformation through the extraordinary scientific and technological advancements in stem cell therapy. It will revolutionize the entire healthcare system if these therapies are fully implemented, and Cellebration Life Sciences Inc. is relentlessly working to turn this into reality.

What Diseases Can be Treated with Stem Cell Therapy?

If stem cell therapy comes into the mainstream in the upcoming days, curing several fatal diseases biologically will be possible. These are:

  • Alzheimer’s
  • Parkinson’s
  • Diabetes (Type 1 and Type 2)
  • Autoimmune Diseases
  • Autism
  • COPD
  • Orthopedic
  • Kidney & Liver related diseases
  • Stroke
  • Anti-aging
  • Skin Burn
  • Chronic pain
  • Cancer
  • Skin and dermatological ailments


The Stem Cell and Cellular Therapies market is anticipated to reach $200 Billion by 2025 globally. The sector is becoming a multi-billion dollar industry due to its lower-cost models than traditional medicines.

Challenges to Stem Cell Therapy

Though there are various applications of stem cells in regenerative treatment such as burned skin or the aging of skin etc., as the stem cell therapy research is in its nascent stage, there are a few roadblocks on the path to attaining the complete result:

  • Manufacturing Issue
    • This is one of the significant emerging problems in stem cell therapy. Before administering stem cells to a human person, full attention to the production process and the product’s characterization and official safety evaluation can not be overlooked at any cost.
  • Genetic Instability
    • The genetic instability of stem cells is another issue stem cell treatment faces internationally. Before beginning any cell-based therapy, it is crucial to do a thorough genetic analysis, including chromosomal abnormalities and genome karyotyping.
  • Pharmacological Issue
    • The chemical sensitivity in stem cells is high. The treatment given during or after a transplant for various reasons, such as transplant rejection or a decline in immunity at the time of the transplant, may sometimes impact the delivered stem cells.


Therefore, proper clinical trials should be undertaken before making it mainstream.

The mission at Cellebration is to be a catalyst for change, bringing stem cell therapy to the world and hastening the end of humanity’s most significant health challenges.

Can Stem Cell Therapy successfully treat “Incurable Diseases” such as Diabetes?

Around 30% of the world population is overweight, and as per the U.S. Department of Health and Human Services, more than 37 million Americans are predisposed to Type 2 diabetes.

In a clinical study involving Dr. Anand and 45 patients, insulin consumption per patient was reduced by up to 70%. This success will alter the way Type 2 diabetes is currently treated.

The success of the clinical trial of Cellebration is expected to transform the worldwide strategy for treating this chronic disease and we believe it will bring significant benefits to Cellebration’s shareholders. Not only Diabetes, Cellebration will also conduct additional clinical trials for other auto-immune ailments, such as arthritis and Crohn’s disease.

Why have you decided to collaborate with Dr. Anand Srivastava?

Dr. Anand Srivastava is widely viewed as the father of stem cell research. He is recognized for his stem cell research in the United States, India, Japan, Poland, Saudi Arabia, and Mexico.

Dr. Anand Srivastava, co-founder of Cellebration has helped develop stem cell research programs for various prestigious American institutions. These are the University of California San Diego UCSD; Salk Research Institute, San Diego, California; the University of California Irvine UCI; Burnham Institute of Medical Research San Diego, California; and the University of California Los Angeles or UCLA.

Dr. Anand and Cellebration have been recognized by several governments globally for their work and rely on his expertise and guidance to determine policy, best practices, and safety procedures. Further, the team has received the prestigious Best in Business award by the United States Government for research and service in treating debilitating diseases. Dr. Anand is credited with

many fundamental creations that have made the entire modern stem cell science industry possible.

Scientists and doctors in the field of stem cells have found Dr. Anand’s discoveries, innovations, and publications very useful. Dr. Anand is a renowned speaker and provided his reviews in various industry journals. Furthermore, while working at UC Irvine, Dr. Anand and his team conducted the First FDA-approved Human Clinical Trial with other specialists such as the Christopher and Dana Reeves Foundation in 2007.

Founded in 2020 under Tim Kopatich, Cellebration Life Sciences Inc is a stem cell research-based organization. It collaborated with Dr. Anand Srivastava to treat the human body organically with the help of stem cells.

In an interview with Fintech. Tv, I’ve stated, “We are doing a $20 million fundraising to do two things: One would be Offshore treatment centers, one in Costa Rica and one in Mexico, and other places. But the main research focus is a Type 2 Diabetes clinical study performed in India, where it showed a reduction of insulin intake for Type 2 Diabetics of up to 70%.” Cellebration Life Sciences Inc aims to take type 2 diabetes protocols through an official FDA Phase 1 Clinical trial where the company is confident that it will show the same results as its’ clinical study. Once this trial is completed, the company expects the IP to have substantial value for its shareholders.

Role of Cellebration in Promoting Stem Cell Research

Our team is partnered with the top researchers, scientists, inventors, and doctors in stem cell science. We endeavor to provide promising solutions to those patients across the world who are suffering from degenerative and genetic diseases. Our mission is to act as a catalyst for this transformation, bring safe and effective stem cell therapies to the world, and eliminate humanity’s most significant health challenges.

Along with Dr. Anand and his team of stem cell specialists worldwide, Cellebration Life Sciences is committed to making the most advanced and elite science available to the world’s people through safe, affordable, and effective means.

To conclude, Stem cell therapy is the subsequent generation therapy that is creating curative treatments for almost every disease. Cellebration looks forward to sharing this incredible science with people globally, who will be amazed to see the magical benefits of these remarkable therapies.


How Can We Help You?

Contact us to get more information: